Table 1 Synthetic Peptides, first vaccination and immunomonitoring
ID | Amino acid (AA) sequence | HLA-restriction | Source protein | AA position within source protein |
|---|---|---|---|---|
ADV-Hex | LTDLGQNLLY | HLA-A*01 | Human adenovirus 5, Hexon protein (HAdV-5, hex) | 885–894 |
FLU-NCAP | ELRSRYWAI | HLA-B*08 | Influenza A virus, Nucleoprotein (H1N1, np) | 380–388 |
EBV-GP350 | PRPVSRFLGNNSILY | HLA-DR | Epstein-Barr virus, Envelope Glycoprotein GP350 (EBV, gp350) | 268–282 |
Control peptides used for immunomonitoring only | ||||
HIV-A*01 | GSEELRSLY | HLA-A*01 | Human Immunodeficiency virus 1, Gag-Pol polyprotein (HIV-1, gag-pol) | 71–79 |
HIV-B*08 | GGKKKYKL | HLA-B*08 | Human Immunodeficiency virus 1, Gag-Pol polyprotein (HIV-1, gag-pol) | 24–31 |
Fil-A | ETVITVDTKAAGKGK | HLA-DR | Human Filamin A protein (FLNA) | 1669–1683 |